Candida Prosthetic Valve Endocarditis Cured by Caspofungin Therapy without Valve Replacement | Zendy

Rajkumar Rajendram | Zendy; N. J. | Zendy; Andrew R.J. Mitchell | Zendy; I.C.J.W. Bowler | Zendy; J C Forfar | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Candida Prosthetic Valve Endocarditis Cured by Caspofungin Therapy without Valve Replacement

Author(s) -

Rajkumar Rajendram,

N. J.,

Andrew R.J. Mitchell,

I.C.J.W. Bowler,

J C Forfar

Publication year - 2005

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/429322

Subject(s) - medicine , caspofungin , candida krusei , mitral valve replacement , endocarditis , prosthesis , surgery , heart valve , mitral valve , valve replacement , antifungal , fluconazole , dermatology , stenosis

A 64-year-old woman with a mechanical mitral valve prosthesis developed late-onset Candida endocarditis. Blood cultures grew Candida glabrata and Candida krusei. Transesophageal echocardiography demonstrated vegetations on the valve. The patient was not medically fit for valve replacement, but her condition was successfully treated with 6 weeks of intravenous caspofungin therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research